LIST OF TABLES
TABLE 1. GLOBAL MALE HYPOGONADISM MARKET, BY DRUG DELIVERY, 2020-2030,($MILLION)
TABLE 2. MALE HYPOGONADISM MARKET REVENUE, FOR TOPICAL GELS, BY REGION , 2020-2030,($MILLION)
TABLE 3. MALE HYPOGONADISM MARKET TOPICAL GELS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. MALE HYPOGONADISM MARKET REVENUE, FOR INJECTABLES, BY REGION , 2020-2030,($MILLION)
TABLE 5. MALE HYPOGONADISM MARKET INJECTABLES BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. MALE HYPOGONADISM MARKET REVENUE, FOR TRANSDERMAL PATCHES, BY REGION , 2020-2030,($MILLION)
TABLE 7. MALE HYPOGONADISM MARKET TRANSDERMAL PATCHES BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. MALE HYPOGONADISM MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 9. MALE HYPOGONADISM MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 10. GLOBAL MALE HYPOGONADISM MARKET, BY THERAPY, 2020-2030,($MILLION)
TABLE 11. MALE HYPOGONADISM MARKET REVENUE, FOR TESTOSTERONE REPLACEMENT THERAPY, BY REGION , 2020-2030,($MILLION)
TABLE 12. MALE HYPOGONADISM MARKET TESTOSTERONE REPLACEMENT THERAPY BY COUNTRY, 2020-2030,($MILLION)
TABLE 13. MALE HYPOGONADISM MARKET REVENUE, FOR GONADOTROPIN AND GONADOTROPIN RELEASING HORMONE THERAPY, BY REGION , 2020-2030,($MILLION)
TABLE 14. MALE HYPOGONADISM MARKET GONADOTROPIN AND GONADOTROPIN RELEASING HORMONE THERAPY BY COUNTRY, 2020-2030,($MILLION)
TABLE 15. GLOBAL MALE HYPOGONADISM MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 16. MALE HYPOGONADISM MARKET REVENUE, FOR KLINEFELTERS SYNDROME, BY REGION , 2020-2030,($MILLION)
TABLE 17. MALE HYPOGONADISM MARKET KLINEFELTERS SYNDROME BY COUNTRY, 2020-2030,($MILLION)
TABLE 18. MALE HYPOGONADISM MARKET REVENUE, FOR KALLMANN SYNDROME, BY REGION , 2020-2030,($MILLION)
TABLE 19. MALE HYPOGONADISM MARKET KALLMANN SYNDROME BY COUNTRY, 2020-2030,($MILLION)
TABLE 20. MALE HYPOGONADISM MARKET REVENUE, FOR PITUITARY DISORDERS, BY REGION , 2020-2030,($MILLION)
TABLE 21. MALE HYPOGONADISM MARKET PITUITARY DISORDERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. MALE HYPOGONADISM MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
TABLE 23. MALE HYPOGONADISM MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
TABLE 24. MALE HYPOGONADISM MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 25. NORTH AMERICA MALE HYPOGONADISM MARKET, BY DRUG DELIVERY, 2020-2030,($MILLION)
TABLE 26. NORTH AMERICA MALE HYPOGONADISM MARKET, BY THERAPY, 2020-2030,($MILLION)
TABLE 27. NORTH AMERICA MALE HYPOGONADISM MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 28. NORTH AMERICA MALE HYPOGONADISM MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 29. U.S. MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 30. U.S. MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 31. U.S. MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 32. CANADA MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 33. CANADA MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 34. CANADA MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 35. MEXICO MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 36. MEXICO MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 37. MEXICO MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 38. EUROPE MALE HYPOGONADISM MARKET, BY DRUG DELIVERY, 2020-2030,($MILLION)
TABLE 39. EUROPE MALE HYPOGONADISM MARKET, BY THERAPY, 2020-2030,($MILLION)
TABLE 40. EUROPE MALE HYPOGONADISM MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 41. EUROPE MALE HYPOGONADISM MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 42. GERMANY MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 43. GERMANY MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 44. GERMANY MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 45. FRANCE MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 46. FRANCE MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 47. FRANCE MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 48. U.K. MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 49. U.K. MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 50. U.K. MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 51. REST OF EUROPE MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 52. REST OF EUROPE MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 53. REST OF EUROPE MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 54. ASIA-PACIFIC MALE HYPOGONADISM MARKET, BY DRUG DELIVERY, 2020-2030,($MILLION)
TABLE 55. ASIA-PACIFIC MALE HYPOGONADISM MARKET, BY THERAPY, 2020-2030,($MILLION)
TABLE 56. ASIA-PACIFIC MALE HYPOGONADISM MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 57. ASIA-PACIFIC MALE HYPOGONADISM MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 58. JAPAN MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 59. JAPAN MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 60. JAPAN MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 61. CHINA MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 62. CHINA MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 63. CHINA MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 64. INDIA MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 65. INDIA MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 66. INDIA MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 67. REST OF ASIA-PACIFIC MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 68. REST OF ASIA-PACIFIC MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 69. REST OF ASIA-PACIFIC MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 70. LAMEA MALE HYPOGONADISM MARKET, BY DRUG DELIVERY, 2020-2030,($MILLION)
TABLE 71. LAMEA MALE HYPOGONADISM MARKET, BY THERAPY, 2020-2030,($MILLION)
TABLE 72. LAMEA MALE HYPOGONADISM MARKET, BY TYPE, 2020-2030,($MILLION)
TABLE 73. LAMEA MALE HYPOGONADISM MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 74. LATIN AMERICA MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 75. LATIN AMERICA MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 76. LATIN AMERICA MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 77. MIDDLE EAST MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 78. MIDDLE EAST MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 79. MIDDLE EAST MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 80. AFRICA MALE HYPOGONADISM MARKET BY DRUG DELIVERY 2020-2030,($MILLION)
TABLE 81. AFRICA MALE HYPOGONADISM MARKET BY THERAPY 2020-2030,($MILLION)
TABLE 82. AFRICA MALE HYPOGONADISM MARKET BY TYPE 2020-2030,($MILLION)
TABLE 83.ALLERGAN PLC: COMPANY SNAPSHOT
TABLE 84.ALLERGAN PLC: OPERATING SEGMENTS
TABLE 85.ALLERGAN PLC: PRODUCT PORTFOLIO
TABLE 86.ALLERGAN PLC: NET SALES,
TABLE 87.ALLERGAN PLC: KEY STRATERGIES
TABLE 88.PFIZER INC.: COMPANY SNAPSHOT
TABLE 89.PFIZER INC.: OPERATING SEGMENTS
TABLE 90.PFIZER INC.: PRODUCT PORTFOLIO
TABLE 91.PFIZER INC.: NET SALES,
TABLE 92.PFIZER INC.: KEY STRATERGIES
TABLE 93.BAYER AG: COMPANY SNAPSHOT
TABLE 94.BAYER AG: OPERATING SEGMENTS
TABLE 95.BAYER AG: PRODUCT PORTFOLIO
TABLE 96.BAYER AG: NET SALES,
TABLE 97.BAYER AG: KEY STRATERGIES
TABLE 98.ELI LILLY AND COMPANY LTD.: COMPANY SNAPSHOT
TABLE 99.ELI LILLY AND COMPANY LTD.: OPERATING SEGMENTS
TABLE 100.ELI LILLY AND COMPANY LTD.: PRODUCT PORTFOLIO
TABLE 101.ELI LILLY AND COMPANY LTD.: NET SALES,
TABLE 102.ELI LILLY AND COMPANY LTD.: KEY STRATERGIES
TABLE 103.ENDO INTERNATIONAL PLC.: COMPANY SNAPSHOT
TABLE 104.ENDO INTERNATIONAL PLC.: OPERATING SEGMENTS
TABLE 105.ENDO INTERNATIONAL PLC.: PRODUCT PORTFOLIO
TABLE 106.ENDO INTERNATIONAL PLC.: NET SALES,
TABLE 107.ENDO INTERNATIONAL PLC.: KEY STRATERGIES
TABLE 108.MERCK & CO., INC.: COMPANY SNAPSHOT
TABLE 109.MERCK & CO., INC.: OPERATING SEGMENTS
TABLE 110.MERCK & CO., INC.: PRODUCT PORTFOLIO
TABLE 111.MERCK & CO., INC.: NET SALES,
TABLE 112.MERCK & CO., INC.: KEY STRATERGIES
TABLE 113.FERRING: COMPANY SNAPSHOT
TABLE 114.FERRING: OPERATING SEGMENTS
TABLE 115.FERRING: PRODUCT PORTFOLIO
TABLE 116.FERRING: NET SALES,
TABLE 117.FERRING: KEY STRATERGIES
TABLE 118.FINOX BIOTEC: COMPANY SNAPSHOT
TABLE 119.FINOX BIOTEC: OPERATING SEGMENTS
TABLE 120.FINOX BIOTEC: PRODUCT PORTFOLIO
TABLE 121.FINOX BIOTEC: NET SALES,
TABLE 122.FINOX BIOTEC: KEY STRATERGIES
TABLE 123.TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 124.TEVA PHARMACEUTICAL INDUSTRIES LTD.: OPERATING SEGMENTS
TABLE 125.TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 126.TEVA PHARMACEUTICAL INDUSTRIES LTD.: NET SALES,
TABLE 127.TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATERGIES
TABLE 128.PERRIGO COMPANY PLC: COMPANY SNAPSHOT
TABLE 129.PERRIGO COMPANY PLC: OPERATING SEGMENTS
TABLE 130.PERRIGO COMPANY PLC: PRODUCT PORTFOLIO
TABLE 131.PERRIGO COMPANY PLC: NET SALES,
TABLE 132.PERRIGO COMPANY PLC: KEY STRATERGIES LIST OF FIGURES
FIGURE 1.MALE HYPOGONADISM MARKET SEGMENTATION
FIGURE 2.MALE HYPOGONADISM MARKET,2020-2030
FIGURE 3.MALE HYPOGONADISM MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.MALE HYPOGONADISM MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.MALE HYPOGONADISM MARKET,BY DRUG DELIVERY,2020(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF TOPICAL GELS MALE HYPOGONADISM MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INJECTABLES MALE HYPOGONADISM MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF TRANSDERMAL PATCHES MALE HYPOGONADISM MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS MALE HYPOGONADISM MARKET,2020-2030(%)
FIGURE 17.MALE HYPOGONADISM MARKET,BY THERAPY,2020(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF TESTOSTERONE REPLACEMENT THERAPY MALE HYPOGONADISM MARKET,2020-2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF GONADOTROPIN AND GONADOTROPIN RELEASING HORMONE THERAPY MALE HYPOGONADISM MARKET,2020-2030(%)
FIGURE 20.MALE HYPOGONADISM MARKET,BY TYPE,2020(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF KLINEFELTERS SYNDROME MALE HYPOGONADISM MARKET,2020-2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF KALLMANN SYNDROME MALE HYPOGONADISM MARKET,2020-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PITUITARY DISORDERS MALE HYPOGONADISM MARKET,2020-2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS MALE HYPOGONADISM MARKET,2020-2030(%)
FIGURE 25.MALE HYPOGONADISM MARKET BY REGION,2020
FIGURE 26.U.S. MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 27.CANADA MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 28.MEXICO MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 29.GERMANY MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 30.FRANCE MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 31.U.K. MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 32.REST OF EUROPE MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 33.JAPAN MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 34.CHINA MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 35.INDIA MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 36.REST OF ASIA-PACIFIC MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 37.LATIN AMERICA MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 38.MIDDLE EAST MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 39.AFRICA MALE HYPOGONADISM MARKET,2020-2030($MILLION)
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44.COMPETITIVE DASHBOARD
FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 46.ALLERGAN PLC.: NET SALES ,($MILLION)
FIGURE 47.PFIZER INC..: NET SALES ,($MILLION)
FIGURE 48.BAYER AG.: NET SALES ,($MILLION)
FIGURE 49.ELI LILLY AND COMPANY LTD..: NET SALES ,($MILLION)
FIGURE 50.ENDO INTERNATIONAL PLC..: NET SALES ,($MILLION)
FIGURE 51.MERCK & CO., INC..: NET SALES ,($MILLION)
FIGURE 52.FERRING.: NET SALES ,($MILLION)
FIGURE 53.FINOX BIOTEC.: NET SALES ,($MILLION)
FIGURE 54.TEVA PHARMACEUTICAL INDUSTRIES LTD..: NET SALES ,($MILLION)
FIGURE 55.PERRIGO COMPANY PLC.: NET SALES ,($MILLION